Interview with the leader of this evaluation study, Marie-Christine Descombes about her positive experiences with this new rapid MDx testing system to detect HSV1 and HSV2 directly from swab samples in 60 minutes with less than 10 minutes Hands-On time. Click here.
- info@buhlmannlabs.ch
- +41 61 487 12 12
News
BÜHLMANN Laboratories AG is proud to announce the achievement of ISO 9001:2008, EN ISO 13485:2012 + AC:2012 re-certification and ISO 13485:2003 for CMDCAS from TÜV SÜD Product Service GmbH / TÜV SÜD America Inc. for our Quality Management System, demonstrating our commitment to the quality of our IVD products. It is a great achievement that shows
In autumn 2015 BÜHLMANN will launch a new generation of faecal calprotectin assay. The BÜHLMANN fCAL™turbo, the next step in automation of faecal calprotectin quantification. Fecal calprotectin (fCAL) is the most important marker for in vitro diagnostic detection of gut inflammation. Immunological quantitation is well established and is used in the diagnostic work-up of inflammatory
Basel, April 2nd, 2015 – BÜHLMANN is pleased to announce the launch of IBDoc®, the first in-vitro diagnostic test to measure the fecal inflammation marker calprotectin at home. IBDoc® just received a CE mark for patient self testing and is a revolutionary new test for gut inflammation aimed at people with Inflammatory Bowel Disease, Crohn’s and Ulcerative Colitis.
Social Links